Link copied to clipboard!

Cura Care raises Rs 5 Cr in Pre-Seed Funding for At-Home Oral Wellness Services

IMT News Desk
IMT News Desk
· 1 min read

The company also focuses on building a scalable expansion strategy for long-term growth

Cura Care, India’s first at-home wellness services brand has successfully raised Rs 5 crore in a pre-seed funding round led by Zeropearl VC, with participation from friends, family, and notable angel investors, including Shripad Nadkarni and the late Rohan Mirchandani. 

The brand plans to utilise the funds raised to validate its product-market fit and enhance its customer promise by delivering exceptional at-home wellness experiences. The company also focuses on building a scalable expansion strategy for long-term growth in India’s current $60 billion wellness market.

The company aims to integrate oral wellness into the daily self-care routines of Indians, providing a seamless booking experience and exceptional service quality.

The Co-founders of Cura Caresaid, “We are happy to welcome Bipin Shah to our board. He shares our strong commitment to building an experience-led, convenience-first oral wellness brand. By building an ecosystem of highly skilled doctors, Cura Care is committed to consistently delivering best-in-class services. Through this investment, we have embarked on a path to achieve our vision of redefining and setting new benchmarks in the oral wellness space.

Read Next

Granules India posts Rs 13,879 million revenue from operations at Q3FY26
Finance
January 28, 2026

Granules India posts Rs 13,879 million revenue from operations at Q3FY26

Net debt stood at Rs 10,151 million and net debt to EBITDA at 0.91x Granules India has announced its financial results for the quarter ended December 31, 2025. Revenue from Operations of Q3FY26 stood at Rs 13,879 million, a growth of 22 per cent YoY driven by Finished Dosages (FD) segment in North America and […]
Article by: IMT News Desk
OneSource Pharma’s revenue down at Rs 2,903 million in Q3FY26
Finance
January 28, 2026

OneSource Pharma’s revenue down at Rs 2,903 million in Q3FY26

Impacted by delayed semaglutide approvals in Canada OneSource has posted the Q3FY26 results. Revenues were at Rs 2,903 million, down 26 per cent YoY, impacted by delayed semaglutide approvals in Canada. The EBITDA was at Rs 173 million, down 88 per cent YoY, due to lower revenue in the quarter and largely fixed cost base. […]
Article by: IMT News Desk
Syngene International’s Q3 revenue from operations dip 3% year-on-year to Rs 917 Cr
Finance
January 27, 2026

Syngene International’s Q3 revenue from operations dip 3% year-on-year to Rs 917 Cr

Reported revenue dips to Rs 932 crore in the same quarter Syngene International announced financial results for the third quarter of FY26. Peter Bains, Managing Director and CEO, Syngene International, said, “Our Q3 performance reflects the ongoing impact related to a single product from one of our large-molecule biologics clients. Outside of this factor, the […]
Article by: IMT News Desk
Sigachi Industries aims to increase revenue potential by Rs 250 cr commencing from Q427
Finance
January 27, 2026

Sigachi Industries aims to increase revenue potential by Rs 250 cr commencing from Q427

Sigachi’s entry into CF APIs positions the company in a structurally strong and innovation-led therapeutic segment with long-term demand visibility Sigachi Industries announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. The development marks […]
Article by: IMT News Desk